Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06988306 · ClinicalTrials.gov registry record · NA
Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs
A NA study of Diabetes Mellitus and Gestational Diabetes Mellitus (GDM), sponsored by California Polytechnic State University-San Luis Obispo.
- Recruiting
- Registry status
- NA
- Development phase
- 978
- Enrollment target
- 3
- Study locations
NCT06988306: Recruiting NA study of Diabetes Mellitus and Gestational Diabetes Mellitus (GDM), sponsored by California Polytechnic State University-San Luis Obispo.
NCT06988306 is a NA study of Diabetes Mellitus and Gestational Diabetes Mellitus (GDM) that is actively recruiting participants, run by California Polytechnic State University-San Luis Obispo. The registered enrollment target is 978 participants, below the 1,863-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (48% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06988306, a NA study of Diabetes Mellitus and Gestational Diabetes Mellitus (GDM), is actively recruiting participants, sponsored by California Polytechnic State University-San Luis Obispo.
- RECRUITING
- Registry status
- NA
- Development phase
- 978 participants
- Enrollment target
- 3
- Study locations
Study Summary
The study is examining the health effects of gestational diabetes mellitus (GDM) intervention and medically tailored meals within home visiting. A large study is proposed that will include nearly a thousand pregnant or recently pregnant adults with recent GDM and who are from different regions and backgrounds. Two treatment approaches are compared, and both are in home visiting. One treatment group is receiving enhanced lifestyle support for GDM along with meals, and the other is receiving just the enhanced lifestyle support. The study will examine whether these interventions help reduce diabetes and pre-diabetes through 12 months postpartum, as well as other health factors like weight and blood pressure.
Primary Outcome
The Primary Outcome Measure in this study is a categorical outcome of glucose tolerance (i.e., healthy glucose tolerance vs. type 2 diabetes/pre-diabetes) at 12 months postpartum. The test will be conducted at CLIA-certified lab. A 2-hour oral glucose tolerance test (OGTT) will characterize people into one of two categories: 1) healthy glucose tolerance; or 2) type 2 diabetes (2-hour post 75g load glucose level of 200 mg/dL or greater) or pre-diabetes (a 2-hour post 75g load glucose level of 140
Conditions Studied
Interventions
- BEHAVIORAL GDM Enhanced
- BEHAVIORAL Meals
Study Locations (3)
California
- California Polytechnic State University - San Luis Obispo
Illinois
- Northwestern University - Chicago
Rhode Island
- Miriam Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 978 participants |
| Start Date | 2026-01-15 |
| Est. Completion | 2030-04-30 |
| Phase | NA |
What NCT06988306 shows while recruiting
NCT06988306 is an interventional study that assigns participants to a tested intervention. The registered 978 participants enrollment target is mid-sized for trials with a published cap, below the 1,863-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (48% lower).
The record links to 2 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which GDM Enhanced is the first listed.
NCT06988306 reports a single indexed study location in California, Illinois, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT06988306 about?
NCT06988306 is a clinical study titled "Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs". The study is examining the health effects of gestational diabetes mellitus (GDM) intervention and medically tailored meals within home visiting. A large study is proposed that will include nearly a thousand pregnant or recently pregnant adults with recent GDM and who are from different regions and b...
What is the current status of trial NCT06988306?
This trial is currently recruiting. It is a NA study. The enrollment target is 978 participants. The study started on 2026-01-15. Estimated completion is 2030-04-30.
What conditions does trial NCT06988306 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Gestational Diabetes Mellitus (GDM).
What interventions are being tested in trial NCT06988306?
The interventions under investigation include: GDM Enhanced (BEHAVIORAL), Meals (BEHAVIORAL).
Who is sponsoring clinical trial NCT06988306?
This trial is sponsored by California Polytechnic State University-San Luis Obispo, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06988306 being conducted?
This trial has 3 study locations across California, Illinois, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06988306's enrollment target sits among peer trials
978 28th of 208 higher than 181 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06337097 · 980 participants · NA
STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy
- NCT07070232 · 980 participants · Phase 1
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- NCT07184931 · 980 participants · Phase 3
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- NCT07184996 · 980 participants · Phase 3
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI